Chae Yin Cher

Title: Innovations by Chae Yin Cher in Genomic Detection

Introduction

Chae Yin Cher is an accomplished inventor based in Singapore, known for his significant contributions to the field of genomic research. His innovative work focuses on methods for detecting and quantifying genomic and gene expression alterations using RNA. With a patent portfolio that includes a groundbreaking method, Cher is making strides in the scientific community.

Latest Patents

Chae Yin Cher holds a patent for a method of detecting and quantifying genomic and gene expression alterations using RNA. This method involves determining the presence or absence of genomic alterations and quantifying gene expression levels in biological samples. The process includes variant calling from sequence alignments, identifying differences between consensus reads and reference genomes, and determining read counts of sequence alignments that exhibit genomic alterations. The patent also encompasses a kit designed for these detection and quantification processes.

Career Highlights

Cher is currently associated with Lucence Life Sciences Pte Ltd., where he applies his expertise in genomic research. His work at Lucence Life Sciences has positioned him as a key player in advancing technologies that enhance our understanding of genetic variations and their implications in health and disease.

Collaborations

Chae Yin Cher collaborates with talented individuals in his field, including Yukti Choudhury and Jia Min Ho. These collaborations foster an environment of innovation and shared knowledge, contributing to the advancement of genomic research.

Conclusion

Chae Yin Cher's contributions to genomic detection and quantification represent a significant advancement in the field. His innovative methods and collaborative efforts continue to push the boundaries of scientific research, paving the way for future discoveries in genomics.